Search research articles
Contact Us
Filters
Showing results (1-10 of 114) with videos related to
Page
of 12
Sort By:
Brachytherapy
|
July 3, 2010
Point: Prostate carcinoma treatment for the young patient--the case for brachytherapy
Kent E Wallner
Brachytherapy
|
February 19, 2013
Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy"
Kent E Wallner
Reviews in Urology
|
November 14, 2013
The case for hypofractionation of localized prostate cancer
Winnifred M Wong, Kent E Wallner
Oncology (Williston Park, N.Y.)
|
October 10, 2006
Treatment of prostate cancer in obese patients
Hiroki Mitsuyama, Kent E Wallner, Gregory S Merrick
Oncology (Williston Park, N.Y.)
|
October 7, 2010
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?
L Christine Fang, Gregory S Merrick, Kent E Wallner
Urology
|
November 20, 2003
Minimizing prostate brachytherapy-related morbidity
Gregory S Merrick, Kent E Wallner, Wayne M Butler
The Journal of Urology
|
April 11, 2003
Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Urology
|
July 5, 2005
Prostate cryotherapy: more questions than answers
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Oncology (Williston Park, N.Y.)
|
February 26, 2003
Management of sexual dysfunction after prostate brachytherapy
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Mayo Clinic Proceedings
|
July 13, 2004
Morbidity after brachytherapy for prostate adenocarcinoma
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Page
of 12
Search research articles
Search
Showing results (1-10 of 114) with videos related to
Sort By:
Page
of 12
Brachytherapy
|
July 3, 2010
Point: Prostate carcinoma treatment for the young patient--the case for brachytherapy
Kent E Wallner
Brachytherapy
|
February 19, 2013
Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy"
Kent E Wallner
Reviews in Urology
|
November 14, 2013
The case for hypofractionation of localized prostate cancer
Winnifred M Wong, Kent E Wallner
Oncology (Williston Park, N.Y.)
|
October 10, 2006
Treatment of prostate cancer in obese patients
Hiroki Mitsuyama, Kent E Wallner, Gregory S Merrick
Oncology (Williston Park, N.Y.)
|
October 7, 2010
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?
L Christine Fang, Gregory S Merrick, Kent E Wallner
Urology
|
November 20, 2003
Minimizing prostate brachytherapy-related morbidity
Gregory S Merrick, Kent E Wallner, Wayne M Butler
The Journal of Urology
|
April 11, 2003
Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Urology
|
July 5, 2005
Prostate cryotherapy: more questions than answers
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Oncology (Williston Park, N.Y.)
|
February 26, 2003
Management of sexual dysfunction after prostate brachytherapy
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Mayo Clinic Proceedings
|
July 13, 2004
Morbidity after brachytherapy for prostate adenocarcinoma
Gregory S Merrick, Kent E Wallner, Wayne M Butler
Page
of 12